Pharma & Biotech
A look back at some of the more interesting stories from London's junior market over the past week
Shield Therapeutics encouraged by US interest in iron deficiency treatment
Oncimmune continues building momentum with partnerships
Motif Bio calls time on iclaprim and to become cash shell
Only registered members can use this feature.
© Proactive Investors 2021.
Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority. Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.